24th Annual Biotech in Europe Forum

FOR GLOBAL PARTNERING & INVESTMENT

25th - 26th of September 2024|MÖVENPICK HOTEL | BASEL | SWITZERLAND

Investors:

+ND Capital

3B Future Health Ventures

3xP Global

4BIO Capital

Accequa AB

AdBio Partners

aescuvest GmbH

AFK & Partners LLC

Agile Capital Markets

Aliath Bioventures

Allele Capital Partners

ALSA Ventures

AMR Action Fund GP GmbH

Andera Partners SA

Angelini Ventures S.p.A.

Antisoma Venture Capital Fund S.A

Apollo Health Ventures

ArchiMed

ARVE Capital GmbH

Asahi Kasei Ventures

Asklepios Advisors

AurorA Science Srl

AVANTECA Partners AG

Avego Bioscience Capital

Awen GmbH

AXA Investment Managers

BaseLaunch

Bellevue Asset Management AG

Bergaud & Partners

Bergmann zur Hausen & Cie. GmbH

BERNINA BioInvest Ltd.

Bio Med Gene Ventures

BioGeneration Ventures

BioMedPartners AG

BiomedVC AG

Bioqube Ventures

BioValley Basel

Biovance Capital

Biovision Ventures

BlackRock Advisors

Boehringer Ingelheim Venture Fund GmbH

BOLD Longevity Growth Fund

Bootstrap Europe

Bradley Woods & Co. Ltd.

Breslin AG

British Patient Capital

BROTHERS & Partners Europe

Business Angels Switzerland

Carma Fund

Catalpa Ventures S.à r.l.

CDP Venture Capital SGR S.p.A.

CDP Venture Capital SGR ​S.p.A.

Chugai Venture Fund

Claris Ventures

Clave Capital

CMS Medical Venture Investment Ltd.

Convergence Partners AG

Curie.Bio

Danube BioVentures

DeBere Capital Partners

Debiopharm International SA

Delin Ventures Ltd.

Digital Networks PLC

Droia Ventures NV

Endeavor Life Science Venture Fund

ENV Ventures

EQT Life Sciences

European Investment Bank

European Investment Fund

Facultas Partners

FastVentures B.V.

Flagship Pioneering

Forbion

Forty51 Ventures

Fraser Partners

Fund+

G4 FRIENDS LTD.

Generation Fund Life Sciences Fund I

German Accelerator Life Sciences

GIBF

Gilde Healthcare Partners B.V.

Gimv

GL Capital

GOLDTRACK Ventures GmbH

Grabulovski Consulting Services GmbH

GrowthCube Partners LLC

H Tree Capital

H.C. Wainwright & Co.

Hadean Ventures

HBM Partners AG

Heal Capital

Health Innovation Capital

HealthCap

Heran Partners BV

High-Tech Gründerfonds

Hitachi Ventures GmbH

IAG Italian Angels for Growth

ICF Consult Switzerland

Indaco Venture Partners SGR S.p.A.

Index Capital

Innovestor Life Science Ltd.

INOGROUP GmbH

Intercontinental Capital

Inveready Asset Management

IPF Partners

Jeito Capital

JFG Life Sciences Foundation

JPMorgan Chase & Co.

Karista

Kerna Ventures

King Bioventures

Kurma Partners

Ladenburg Thalmann & Co. Inc.

Landmark Angels

Landmark BioVentures AG

LifeCare Partners GmbH

LSA Ventures

LSV Capital Partners

Lynx Financial Hong Kong Ltd.

M Ventures

M2Care

Mid Atlantic Bio Angels

MIG Capital

MSQ Ventures

MVM Partners LLP

Nasdaq

New Science Fund

Nextech Invest Ltd.

NG Bio

Novartis Venture Fund

Novo Holdings A/S

Novo Nordisk A/S

NRW.Venture

NxR Biotechnologies GmbH

Octopus Ventures

Omega Funds

Oncode Oncology Bridge Fund

One Up Consulting

OrbiMed Advisors LLC

Panakès Partners SGR SpA

Peregrine Ventures

Philos & Partners Ltd

Playground Global

PMV NV

Pureos Bioventures

Qiming Venture Partners

Quadrille Capital

Redalpine Venture Partners AG

Rosetta Capital Ltd.

RV Invest GmbH

Sand Hill Angels

Second Thought

Seroba Life Sciences

Seventure Partners

Sixty Degree Capital

Sofinnova Partners

Sound Bioventures Management AB

Staatz BD & Strategy

Stifel

Sunstone Life Science Ventures

Taiho Ventures

TruVenturo GmbH

TVM Capital Life Science

UBS AG

UCEA Family Office

V-Bio Ventures BV

Valor Management

Versant Ventures

Vesalius Biocapital IV Partners SàrL

VI Partners AG

Viopas Venture Consulting

Vogel BioC

WBB Securities

Wellington Partners

XGEN Venture SGR S.p.A.

XOventure GmbH

YAYA Capital

Ysios Capital

Zinc VC

Last updated: October 1, 2024